Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,064 | 437 | 83.8% |
| Consulting Fee | $1,350 | 2 | 16.0% |
| Education | $16.61 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,031 | 129 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,200 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $1,017 | 81 | $0 (2024) |
| Allergan, Inc. | $538.66 | 44 | $0 (2020) |
| PFIZER INC. | $488.14 | 31 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $421.44 | 23 | $0 (2024) |
| Gilead Sciences, Inc. | $408.22 | 24 | $0 (2024) |
| Novo Nordisk Inc | $257.81 | 15 | $0 (2024) |
| Medtronic, Inc. | $237.96 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $180.36 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $769.58 | 44 | GlaxoSmithKline, LLC. ($174.23) |
| 2023 | $952.87 | 50 | ABBVIE INC. ($421.20) |
| 2022 | $1,115 | 68 | ABBVIE INC. ($688.66) |
| 2021 | $2,733 | 98 | Biohaven Pharmaceuticals, Inc. ($1,200) |
| 2020 | $1,465 | 90 | Allergan, Inc. ($347.15) |
| 2019 | $371.72 | 26 | GlaxoSmithKline, LLC. ($128.36) |
| 2018 | $447.55 | 28 | COMSORT, Inc ($150.00) |
| 2017 | $575.82 | 37 | Allergan Inc. ($128.07) |
All Payment Transactions
441 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Biological | ||||||
| 10/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $141.21 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Diabetes Care | ||||||
| 08/31/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Diabetes Care | ||||||
| 05/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes Care | ||||||
| 05/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/11/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: PSYCHIATRY | ||||||
| 04/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,358 | 2,990 | $369,934 | $177,174 |
| 2022 | 13 | 1,229 | 2,988 | $359,715 | $166,365 |
| 2021 | 18 | 1,347 | 3,013 | $348,765 | $158,988 |
| 2020 | 14 | 1,200 | 2,584 | $318,897 | $130,126 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 164 | 867 | $130,050 | $54,185 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 542 | $81,300 | $38,308 | 47.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 167 | 167 | $33,400 | $24,344 | 72.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 232 | $46,400 | $23,902 | 51.5% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 104 | 261 | $19,575 | $9,008 | 46.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 92 | 172 | $15,465 | $8,147 | 52.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 267 | 529 | $15,870 | $4,444 | 28.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 27 | 27 | $6,750 | $4,317 | 64.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 34 | 45 | $9,000 | $4,176 | 46.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $5,800 | $2,364 | 40.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $2,750 | $2,032 | 73.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 69 | 69 | $1,624 | $1,457 | 89.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 39 | $1,950 | $492.84 | 25.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 122 | 886 | $132,900 | $54,531 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 576 | $86,400 | $43,623 | 50.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 207 | $41,400 | $20,175 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 105 | 105 | $21,000 | $15,808 | 75.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 87 | 269 | $20,175 | $10,512 | 52.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 110 | 177 | $15,930 | $8,758 | 55.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 32 | 50 | $10,000 | $4,027 | 40.3% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 19 | 19 | $4,750 | $2,841 | 59.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $5,400 | $2,559 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 267 | 568 | $17,040 | $1,682 | 9.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 64 | 66 | $3,300 | $720.91 | 21.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $600.00 | $589.20 | 98.2% |
About Dr. Girish Patel, M.D
Dr. Girish Patel, M.D is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588644991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Girish Patel, M.D has received a total of $8,430 in payments from pharmaceutical and medical device companies, with $769.58 received in 2024. These payments were reported across 441 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,064).
As a Medicare-enrolled provider, Patel has provided services to 5,134 Medicare beneficiaries, totaling 11,575 services with total Medicare billing of $632,653. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location New York, NY
- Active Since 01/20/2006
- Last Updated 03/28/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588644991
Products in Payments
- NURTEC ODT (Drug) $1,200
- VRAYLAR (Drug) $1,173
- UBRELVY (Drug) $785.14
- TRELEGY ELLIPTA (Drug) $521.72
- FARXIGA (Drug) $320.58
- NUCALA (Biological) $281.03
- CHANTIX (Drug) $241.98
- QULIPTA (Drug) $239.88
- Ozempic (Drug) $195.43
- REXULTI (Drug) $180.36
- XIFAXAN (Drug) $161.84
- COREVALVE EVOLUT R (Device) $160.63
- KEYTRUDA (Biological) $150.00
- Vascepa (Drug) $148.95
- XARELTO (Drug) $141.73
- ELIQUIS (Drug) $135.82
- SYNTHROID (Drug) $127.48
- ONZETRA Xsail (Drug) $114.32
- The MetaNeb System (Device) $113.70
- ENTRESTO (Drug) $113.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M